FdaApplication
NDA 210115
Identifiers
- fda_app_no: NDA210115
Properties
| Property | Value |
|---|---|
| applicant_name | ASTELLAS PHARMA US INC |
| application_type | NDA |
| approval_date | 2018-05-24 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PROGRAF | TACROLIMUS | EQ 0.2MG BASE/PACKET | FOR SUSPENSION;ORAL |
| PROGRAF | TACROLIMUS | EQ 1MG BASE/PACKET | FOR SUSPENSION;ORAL |
2 products